Amazon is a certified hub for Black Friday shopping. While there’s a lot to sort through, a new markdown on a popular scalp serum has caught our eye. Divi’s Scalp Serum is currently 50% off on Amazon ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. If you’ve been eyeing a scalp serum with serious ...

Just in time for Taylor Swift’s new album, Divi is getting into the Showgirl persona with a limited-time sale on top-selling haircare bundles. The exclusive 48-hour sale incorporates favorites, like ...

End-of-summer and fall escapes to the Caribbean are still available – and with Divi Resorts, they’re more affordable than ever. Prices are slashed by one of the most respected names in Caribbean ...

Divi’s Laboratories Ltd, India’s second-largest pharmaceutical company by market capitalization, is expected to report a 14-18% jump in revenue and robust margin expansion for the quarter ended 30 ...

DIVI stands out among international dividend ETFs due to its methodology emphasizing value, earnings stability, and profitability, not just high yield. The ETF's optimization process allows for growth ...

When considering pristine beaches and consistently warm water, Aruba has to be at the top of any world traveler’s list. The constituent island country is famous for its staid climate, which keeps the ...

Divi Resorts is redefining Caribbean travel with a refreshing focus on flexibility, authenticity, and affordability. With seven upscale beachfront properties spread across five captivating ...

Divi Bijesh is a nine-year-old chess prodigy from Thiruvananthapuram who sees 10 moves ahead in the geometry of sixty-four squares — knows when to castle out of trouble, when a knight belongs on the ...

Divi’s Laboratories has signed a long-term manufacturing and supply agreement with a major global pharmaceutical firm, a strategic milestone in its custom synthesis business. The agreement is for the ...

Divi’s Laboratories on Friday announced signing of a long term advanced intermediates manufacturing and supply agreement with a global pharma company and plans to invest atleast ₹650 crore, from ...

Divi's Laboratories on Friday said it has inked a supply agreement with a global pharmaceuticals firm. Under the long-term agreement, the company will be manufacturing and supplying advanced ...